Amicus Therapeutics Inc

Overview

Amicus Therapeutics Inc (Amicus Therapeutics) is a biotechnology company, which focuses on the research, development and commercialization of small molecule drugs and orally administered drugs known as pharmacological chaperones for the treatment of rare and orphan diseases. The company's lead product, migalastat HCl, a small molecule, is indicated for the treatment of Fabry disease. The other products in the pipeline include ATB200/AT2221 for the treatment of Pompe disease, Fabry disease, and other lysosomal storage disorders; migalastat for other conditions; and enzyme replacement therapies for other rare diseases. It has presence in the US, the UK, Ireland, France, the Netherlands, Germany, Spain, Italy and Japan. Amicus Therapeutics is headquartered in Cranbury, New Jersey, the US.
Key Stats
Address
3675 MARKET STREET, PHILADELPHIA, Pennsylvania
Headquarters

United States of America

Contact

1 215 9217600

No of Employees

483

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

FOLD [NASD]

Revenue (2020)

$261 m

43.2% (2020 vs 2019)
Net Income (2020)

$-277 m

22.3% (2020 vs 2019)
Net Profit Margin

-106 %

45.7% (2020 vs 2019)
Market Cap *

$3,036 m

EPS *

$-1.1

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Amicus Therapeutics IncBioMarin Pharmaceutical IncRegeneRx Biopharmaceuticals Inc
Key Information
Headquarters United States of America United States of America United States of America
Headquarter City PHILADELPHIA NOVATO ROCKVILLE
Headquarter State/Province Pennsylvania California Maryland
No. of Employees 483 3,059 3
Entity Type Public Public Public

Products & Services

Amicus Therapeutics specializes in the development of small molecule, orally-administered pharmacological chaperones for the treatment of human genetic diseases. The pipeline products of the company include the following:

Products
  • Migalastat HCl - Fabry disease
  • Pipeline ATB200/AT2221
  • Migalastat
  • Vitae Eget Libero
  • Vitae Eget Libero
Brands
  • Amicus Assist
  • CHART
  • Galafold
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Daphne Quimi Chief Financial Officer Senior Management 2019 55 Ms. Daphne Quimi has been the Chief Financial Officer of Amicus Therapeutics since 2019. She joined the company in October...
David Clark Chief People Officer Senior Management 2018 - Mr. David Clark has been the Chief People Officer at Amicus Therapeutics since October 2018. He previously was the Vice...
Hung Do, PH.D. Chief Scientific Officer Senior Management 2015 - Dr. Hung Do has been the Chief Science Officer of the company since July 2015. Previously, he served as Senior...
Patrik S. Florencio Senior Vice President; Chief Compliance and Risk Officer Senior Management 2015 - Mr. Patrick S. Florencio has been the Senior Vice President and the Chief Compliance and Risk Officer of the company...
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2021 Regulatory Approval In August, the company received the European Commission approval for its Galafold (migalastat) to treat…
2020 Corporate Changes/Expansions In March, the company opened a new global research and gene therapy center of excellence…
2019 Contracts/Agreements In July, the company entered into a gene therapy development and manufacturing collaboration with Brammer…
2019 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2019 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2019 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


Amicus Therapeutics GmbH

Address

Willy-Brandt-Platz 3, 81829 Munchen
Germany

Telephone

49 89 2488 798 10

Amicus Therapeutics UK Ltd

Address

One Globeside, Fieldhouse Lane, Marlow
United Kingdom

Telephone

44 1753 888567

Website

www.amicusrx.co.uk
Scioderm Inc

Address

Suite 200, 160 Mine Lake, Raleigh
United States of America

Telephone

1 919 3282020

Amicus Therapeutics SAS

Address

Maison de La Defense, 12 Place de La Defense, 92974 Paris La Defense Cedex
France

Telephone

33 1 72 75 72 54

Amicus Therapeutics BV

Address

Science Park 402, 1098XH Amsterdam
Netherlands

Telephone

31 20 235 8510

Website

http://www.amicusrx.nl
Callidus Biopharma Inc

Address

3220 Tillman Drive, Suite 301, Bensalem, Bucks
United States of America

Telephone

1 215 4347482

Website

www.callidusbiopharma.com

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
02 Feb 2021 Amicus Therapeutics Files Preliminary Prospectus for Public Offering of Shares for up to USD48.9 Million Equity Offering Amicus Therapeutics Inc
12 Mar 2020 Genesis Pharma Enters into Commercialization Agreement with Amicus Therapeutics Licensing Agreement Genesis Pharma Cyprus Ltd Amicus Therapeutics Inc
18 Dec 2019 Amicus Therapeutics Inc Enters Phase III Clinical Trial Agreement with Medpace Holdings Inc for (cipaglucosidase alfa + miglustat) (GDCT0369954) Contract Service Agreement Amicus Therapeutics Inc; Amicus Therapeutics Inc Medpace Holdings Inc; Medpace Holdings Inc
02 Jul 2019 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
01 Jul 2019 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
29 May 2019 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit

Jobs Overview

34

Active Jobs

19

Posted

13

Closed

Job Trends

Latest Jobs

Job title Company Country
Clinical Trial Manager Amicus Therapeutics Inc United States
Senior Associate – Global Supply Chain Amicus Therapeutics Inc United States
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar